As its seen in 59.25% (16 out 27) of the MM phenotype, 50% (8 out 16) of the LGMD2B phenotype, 37.5% (3 out 8) compound phenotype in addition to one asymptomatic (hyperCKemia) case. This evidence concerns the gene DYSF and Miyoshi myopathy.